Half-year report · Q2
9218.TEDINET S100U88E
Period2024-01-01 → 2024-06-30
Filed2024-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.3bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Revenue | ¥2.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Operating income | −¥96m | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Operating income | ¥217m | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Ordinary income | −¥147m | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥496m | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥213m | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥146m | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥219m | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥202m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥441m | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥158m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥202m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Net income | ¥158m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Total assets | ¥4.3bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥1.5bn | at 2023-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.2bn | at 2024-06-30 | Cons. | Liabilities |
| Total liabilities | ¥618m | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.1bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥823m | at 2023-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥914m | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥914m | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥812m | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥660m | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥29m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥178m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥18m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.9bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥91m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥38m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥2.1bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥167m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥209m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-20 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥44.29 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥41.78 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥14.96 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 21.4% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.3% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.6% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 39
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥26m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥26m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥572m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥52m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥27m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥25m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥11m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥84m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥84m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥26m |
| jpcrp040300-q2r_E37508-000Medical Work Shift Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥939m |
| jpcrp040300-q2r_E37508-000Medical Work Shift Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥939m |
| jpcrp040300-q2r_E37508-000Medical Work Shift Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥109m |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥350,000 |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥330m |
| —segment total | revenue | 2024-01-01 → 2024-06-30 | ¥2.3bn |
| —segment total | revenue external | 2024-01-01 → 2024-06-30 | ¥2.3bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥26m |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥476m |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥53m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥53m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥153m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥84m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥31m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥52m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥36m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥242m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥242m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥135m |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥450,000 |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥198m |
| —segment total | revenue | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| —segment total | revenue external | 2023-01-01 → 2023-06-30 | ¥1.3bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥53m |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥369m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 520
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)かがやき監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)奥村 隆志 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)牛丸 智詞 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 1304409000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 2275812000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 2608600000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 212949000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | -146520000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 495854000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 158118000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | -202151000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 441371000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 158118000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | -202151000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 441371000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 823400000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 1111585000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 1115516000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 1454300000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 4271483000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 1733835000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 16.00 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | -20.00 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 44.29 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 14.96 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 41.78 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.566 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.214 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.643 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | -18449000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 28931000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 177541000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -37717000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -1946310000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -90615000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | 208740000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | 2059418000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 167277000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 812084000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 1055754000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 913714000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 10109300 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 10109300 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 10109300 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 10109300 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 3506000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.3468 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |